Evaluate VCEL stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in VCEL? | Glauxie AI

Q: What are the risks of investing in VCEL?

Vericel Corporation (VCEL) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Dominick C. Colangelo. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care... Employees: 398.

Q: How much debt does VCEL have?

Review VCEL total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is VCEL a good long-term investment?

Evaluate VCEL as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in VCEL?

🦉

Vericel Corporation (VCEL)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODominick C. Colangelo

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI,...

Key Executives

Name	Title
Dominick C. Colangelo	Chief Executive Officer, President & Director
Eric Burns	Vice President of Finance & Investor Relations
Jonathan Hopper FRCSEd.	Chief Medical Officer
Jonathan Siegal	Principal Accounting Officer, Vice President & Corporate Controller
Joseph Anthony Mara Jr.	Chief Financial Officer & Treasurer
Michael Halpin	Chief Operating Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

VCEL Profile Financials

Is VCEL stock safe? How much debt does VCEL have? Is VCEL a good long-term investment?